Vimarsana
Biggest News Aggregation in the World

Page 24 - Current Report News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Report Today - Breaking & Trending Today

ROSEN, A LONGSTANDING LAW FIRM, Encourages Thoughtworks Holding, Inc. Investors to Inquire About Securities Class Action Investigation - TWKS - Vimarsana News

ROSEN, A LONGSTANDING LAW FIRM, Encourages Thoughtworks Holding, Inc. Investors to Inquire About Securities Class Action Investigation - TWKS

NEW YORK, April 29, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor...

Regen BioPharma : Material Event - Form 8-K - Vimarsana News

Regen BioPharma : Material Event - Form 8-K

Item 1.01 Entry into a Material Definitive Agreement. On April 26th 2024 Regen Biopharma, Inc. entered into an agreement with Value Quest, Inc. . Pursuant to the Value Quest...

Direct Selling Acquisition Corp. Announces Delisting of Common Stock and Units from the New York Stock Exchange - Vimarsana News

Direct Selling Acquisition Corp. Announces Delisting of Common Stock and Units from the New York Stock Exchange

Application Pending to Transfer Shares to OTCQX PLANO, Texas, April 29, 2024 /PRNewswire/ -- Direct Selling Acquisition Corp. today announced that it has received a notice letter from the New...

Faraday Future Announces Nasdaq Delisting Determination and Intention to Appeal - Vimarsana News

Faraday Future Announces Nasdaq Delisting Determination and Intention to Appeal

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global sha

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA - Vimarsana News

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA

NEW YORK, April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc.  . Such investors are advised to contact Danielle Peyton at...